Linkage and association studies have detected a role for Calpain-10 (CAPN10) polymorphisms in susceptibility to T2DM in many populations. This study aimed to evaluate possible associations between three SNPs in the CAPN10 (UCSNPs -43, -19 and -63) gene and T2DM in the east Indian population. The distribution of genotype frequency of UCSNP-63 varied significantly between T2DM patients and controls under a dominant model. The uncommon (T) allele (OR = 3.74, 95% CI: 1.44-9.7) of the UCSNP-63 and haplotype 112 (OR = 3.4, 95% CI: 1.17-9.9) were associated with increased risk of T2DM. On the contrary, the most common haplotype 121 (OR = 0.70 95% CI: 0.50-0.99) was associated with a reduced risk for T2DM. In our population a novel 111/112-haplotype combination created by the CAPN10 UCSNP-43, -19 and -63 was associated with risk of T2DM. Haplotypes 112 and 121 with opposite genetic influences also co-exist in our population.
Introduction
T2DM is a multifactorial metabolic disorder having both genetic and non-genetic determinants with genetic components following an uncertain mode of inheritance. 1 The problem of diabetes is growing in epidemic proportions throughout the world and the greatest increase in prevalence is expected to occur in Asia and Africa. 2 Several lines of evidence suggest that the aetio-pathogenesis of the common form of T2DM includes a strong genetic component contributed by several common genetic variants, each with relatively modest effect, which act in combination with each other and with environmental and lifestyle triggers. Genetic variants that have shown to have an association with type 2 diabetes include polymorphisms in Calpain 10 (CAPN10), 3 peroxisome proliferator-activated receptor γ (PPARG-γ), 4 ATP-sensitive inwardly rectifying potassium channel subunit Kir6.2 (KCNJ11), 5 hepatocyte nuclear factor 4-a (HNF4-α/MODY1) 6 and transcription factor-7-like 2 (TCF7L2) 7 genes. Several genes, namely winged helix/ forkhead transcription factor (FOXA2), 8 transcription factor-7-like 2 (TCF7L2), insulin-like growth factor binding protein 2 (IGFBP2), peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC-1α Thr394Thr and Gly482Ser variants), fat mass obesity-associated gene (FTO), 9 apolipoprotein E (APOE) (Hha1) and angiotensin-1 converting enzyme (ACE) (I/D), 10 and IL-4 and IL-1RN 11 100 normoglycemic volunteers collected from a city hospital of Kolkata.
Material and methods

Subjects
A total of 200 T2DM patients (male = 108, female = 92) defined by World Health Organisation criteria participated in this study. Blood samples were also collected from 100 age and sex matched healthy volunteers (male = 54, female = 46) as controls. The 2 h post glucose tolerance test of blood sugar level (after a 75 g glucose load) for diabetic patients is greater than 200 mg/dL (11.11 mmol/L) while the value is less than 140 mg/dL (7.8 mmol/L) for control healthy subjects (without any family history of diabetes or hypertension). The normal glycated haemoglobin (HbA1c) value was less than 6% and that for a diabetic patient was greater than 6%. None of the subjects (both control and patients) were smokers. The individuals belonging to both the groups were unrelated and lived in the eastern Indian province of West Bengal. The study was approved by the Calcutta University Biosafety and Ethics Committee. Informed consent was obtained from all participants.
Genotyping
Genomic DNA isolated from the peripheral blood lymphocyte by the salting out method was used for genotyping of CAPN10 polymorphisms by PCR coupled RFLP method. 13 
Statistical analysis
Hardy-Weinberg equilibrium was tested using the χ 2 goodness-of fit test in T2DM (cases) and healthy subjects (controls) using Haploview (version 3.32). 14 Risk assessment for genotype(s) for all the three loci was performed under co-dominant, dominant and recessive models. Fisher's exact test was applied to examine for differences in allele frequencies in cases and controls. Haplotype frequencies were estimated using Haploview separately in T2DM patients and controls. The frequency of each haplotype was compared between cases and controls against rest of the others pooled as a group as well as with respect to a reference one to estimate the ORs and 95% CIs using a two-way contingency table method. The expected frequencies of diplotype combination were estimated using the Hardy-Weinberg principle. The frequencies of these haplotype combinations in cases and controls were compared with that of the most prevalent diplotype taken as reference. The p-values of at most 0.05 (two-tailed) were considered a statistically significant difference between the two groups.
Results
A total of 200 unrelated patients with T2DM and 100 non-diabetic controls participated in this study. The patients had a mean history of diabetes of 13 years on an average. They had significantly higher levels of post-prandial blood glucose level (12.6 mmol/L) and percentage of glycated haemoglobin (7.32%) compared to those of the control subjects.
Three CAPN10 SNPs, namely UCSNP-43, -19 and -63, were genotyped in all the 300 study participants. The distribution of allele frequencies for these loci did not significantly deviate from Hardy-Weinberg equilibrium for both the diabetic and control groups (p>0.05) (table 1). There were no significant differences in genotype frequencies for UCSNP-43 and -19 between diabetic patients and nondiabetic controls. However, a difference was found in the distribution of genotype frequencies under co-dominant (p-value = 0.025) and dominant (p-value = 0.0079) models for UCSNP-63 between T2DM and normoglycemic individuals, although the former disappeared after BonFerroni correction (table 2). The allele frequencies for UCSNP-43 and -19 did not vary significantly between the two groups while the minor T-allele of UCSNP-63 was found to present The mean frequency+SD of the minor allele of UCSNP-43, -19 and -63 of CAPN10 in the eastern Indian study population. 'n' denotes the sample size in each group. The nucleotide written in italics denotes the minor allele whose frequency is given in the table.
a risk of 3.74 for T2DM (CI: 1.4-9.7; p=0.003) in our sample (table 1) . Haplotypes pertaining to three CAPN10 SNPs and maximum likelihood estimates of their frequencies were obtained using Haploview (table 3) . For UCSNP-43, the G-allele was coded by 1 and the A-allele by 2. For UCSNP-19, 1 represented two repeats of the 32 bp allele and 2 represented three repeats. For UCSNP-63, the C-allele was coded by 1 and the T-allele by 2. A total of eight haplotypes were observed in the patients while six were found in the control samples. The three most common haplotypes are 121, 111 and 221 (table 3). The two haplotypes (122 and 212) that were absent in the control samples were present in very low frequencies in the patients. For association analysis, each CAPN10 haplotype was compared separately with the most frequent one, which was taken as reference haplotype (haplotype 121), and also with the combined frequency of the remaining haplotypes. The frequency of 112 (OR = 3.4, CI: 1.17-9.9) varied significantly between patients and controls in both comparisons. In contrast, the most common haplotype 121 was present in a higher proportion in control samples compared to cases (OR = 1.42 CI: 1.005-1.99) when compared with the pooled ones.
The haplotypes of CAPN10 locus were found to be in Hardy-Weinberg equilibrium. We determined the expected frequencies of various haplotype combinations for cases and controls ( 
Discussion
CAPN10 had been identified as a susceptibility gene in T2DM. Since its discovery upon genome-wide scanning followed by positional cloning, a number of studies 12 15 In our sample, 121 haplotype is present in statistically higher proportion in the normoglycemic group compared to the T2DM patients. Due to the two opposite trends of statistical association of the haplotypes 112 and 121 towards T2DM, the 112/121 haplotype combinations did not differ significantly between the case and control groups in our study.
Haplotype 112 has been detected as a risk haplotype in many other studies. 3, 12 Our finding that haplotype 112 in combination with 111 offers a risk of diabetes is a novel one. The heterozygous combinations of haplotype 111 with 121 and 221 have been found to be associated with high risk of T2DM among Koreans, OR = 2.58 (1.6-4.16) and Utah-Caucasian, OR = 1.48 (1.06-1.91), 16, 17 while an increased risk of diabetes has been detected for homozygous combination of haplotype 121 in a Polish sample. 15 Such divergence observed among studies can be related to the diverse ethnic background of the population under study or to random chance due to a low population frequency of the variant allele. The allele-labelling scheme is followed according to Horikawa et al. In this work, of the three SNPs studied, only the T-allele of UCSNP-63 was found to exert a dominant effect with respect to susceptibility to diabetes. Our finding that haplotype 112 in combination with haplotype 111 confers a risk of T2DM in our population is expected. However, since UCSNP-63 is located in intron 13 of the CAPN10 gene, it may be speculated that an extended haplotype harbouring alleles 1, 1 and 2 at UCSNP-43, -19 and -63, respectively, hosts the actual causal variant that increases an individual's risk of diabetes.
The significance of this study lies in detection of the co-existence of two haplotypes with opposite genetic effects in our population. Haplotype 112 has been detected as a risk haplotype in the eastern Indian population and this finding is in agreement with the majority of genetic studies conducted on CAPN10. 3 On the other hand, the most prevalent haplotype (121) in our population has a significantly higher presence in normoglycemic controls. The ratios of the frequency of the two haplotypes, namely 121 and 112, are 5.6 and 27.5 in the cases and controls, respectively. A very high frequency of haplotype 121 in our sample suggests the existence of a protective haplotype of CAPN10 gene in the eastern Indian population. This reinforces the observation of an earlier association study conducted among the Japanese population. 18 The primary drivers of the epidemic of diabetes are the rapid epidemiological transition associated with changes in dietary patterns and decreased physical activity as evident from the higher prevalence rates of diabetes in the urban population. These changes have resulted in escalating rates of both obesity and diabetes across all age groups and socio-economic levels throughout the world. 19 Lifestyle changes and other environmental factors 20 accompanied by urbanisation adversely affect metabolism and thereby contribute to diabetes as is evidenced by the four to six times higher prevalence of T2DM in urban areas compared to rural areas in India.
The high frequency of protective haplotype 121 in all samples, particularly in the control group, is promising indicating the fact that a healthy lifestyle can probably restrain the burden of diabetes, a common risk factor for cardiovascular and many metabolic disorders. However, the present study has been conducted in a sample set collected from eastern India. A further comprehensive study throughout India may enable us to avoid the skewness that may be present in the current data-set.
In summary, our results indicate the pleiotropic roles of CAPN10 haplotypes with respect to diabetes in our population. The observation of the co-existence of two haplotypes with opposite trends of genetic influence on T2DM in a population is a unique finding. We have not found evidence of the association either of UCSNP-43 and -19 or the haplogenotype 112/121 originally described by Horikawa et al. 12 However, we detected a new combination of haplotypes (112/111) conveying a higher risk to type 2 diabetes in eastern India.
